Jpmorgan Chase & CO Stereotaxis, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 23,473 shares of STXS stock, worth $45,537. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,473
Previous 58,102
59.6%
Holding current value
$45,537
Previous $151,000
72.19%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding STXS
# of Institutions
82Shares Held
41.1MCall Options Held
413KPut Options Held
26.3K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$26.5 Million6.38% of portfolio
-
Lagoda Investment Management, L.P. New York, NY3.95MShares$7.66 Million4.18% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$6.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.03MShares$5.88 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.78MShares$5.4 Million6.2% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $145M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...